Histogen Inc. Announces Common Stock Purchase Agreement for up to $10 Million with Lincoln Park Capital Fund, LLC
July 20, 2020 16:10 ET
|
Histogen Inc
SAN DIEGO, July 20, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (“Histogen” or the “Company”) (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and...
Histogen Announces Completion of Patient Enrollment for its HST 001 Phase 1b/2a Trial for Androgenic Alopecia in Men
July 14, 2020 05:00 ET
|
Histogen Inc
SAN DIEGO, July 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today...
Histogen to Present at BIO Digital 2020
June 03, 2020 08:00 ET
|
Histogen Inc
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...
Histogen Appoints Susan A. Knudson as Chief Financial Officer
May 28, 2020 08:00 ET
|
Histogen Inc
SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...